Ferric Carboxymaltose as Treatment in Women with Iron-Deficiency Anemia
Objective. To evaluate safety and efficacy of intravenous ferric carboxymaltose (FCM) versus standard medical care (SMC) for iron-deficiency anemia (IDA) in postpartum women and women with heavy menstrual bleeding. Study Design. This open-label, multicenter study randomized women with IDA (hemoglobi...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Anemia |
Online Access: | http://dx.doi.org/10.1155/2017/9642027 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|